The OSHA standard for blood-borne pathogens requires that any employee exposed to blood, or other potentially infectious materials (OPIM), follow proper safety precautions when working with needles and other possible contaminated sharps as part of their job duty.
A needle stick or cut from a contaminated sharp is one of the easiest ways health care workers expose themselves to potentially dangerous blood-borne illness, like hepatitis or HIV. Fortunately, most sharps accidents are preventable with the use of proper engineering controls, safe work practices, and personal protective clothing and equipment.
Handling, Storage and Disposal of Needles and Sharps
The best way to prevent cuts and sticks from sharps is to minimize your contact with them. Follow these safety precautions when handling, storing or disposing of sharps:
- Never reach into a contaminated sharps container.
- Never shear or break contaminated sharps.
- Do not recap, bend or remove needles unless medically necessary. If there is no other alternative, make sure to use a mechanical device or one-handed technique.
- Dispose of sharps immediately after use.
- Dispose of contaminated sharps in designated sharps containers only.
Sharps containers should be puncture-resistant, leak-proof and labeled or color-coded red indicating its hazardous contents. Containers for disposable sharps should always have a lid and be maintained in an upright position to keep liquids and sharps inside.
- Do not place contaminated sharps in a full or overfilled sharps container.
- Never open, empty or manually clean a reusable sharps disposal container.
- Close the lid of a contaminated sharps container before disposing of it.
- Place primary sharps containers in secondary containers for disposal if there is any chance the primary container has a leak. Secondary containers should be closable, labeled or color-coded and leak resistant.
Needle Safety
If you are stuck by a needle or other contaminated sharp, or get blood or OPIM in your eyes, nose, mouth, or on broken skin, immediately flood the exposed area with water and clean any wound with soap and water, or a skin disinfectant, if available. Report the incident to your supervisor and seek immediate medical attention.
For more wellness tips, contact INSURICA today.
This is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel or an insurance professional for appropriate advice. © 2023 Zywave, Inc. All rights reserved.
About the Author
Share This Story
Related Blogs
Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now
When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.
The New Era of Mental Health Parity Enforcement in 2026
Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.
The 2026 Specialty Drug Surge: What Employers Need to Prepare For
Specialty drugs have been a major cost driver for years, but 2026 marks a significant shift in both scale and urgency. With GLP 1 medications expanding into new indications, gene therapies entering the market at record pace, and oncology drugs continuing to rise in both cost and utilization, specialty medications are projected to account for more than 60% of total pharmacy spending this year. That’s a dramatic change for employers, especially considering that specialty drugs represent fewer than 5% of total prescriptions.









